Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANTX

AN2 Therapeutics Inc

Jun 11 • 04:00PM ET

4.45

+0.25 5.95 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: BDTX TNYA MOLN HURA MENS MSLE OKUR ORMP PLX SPRB

| Held by: VTI VXF IWC DFAS DFMC DFAC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.10	Insider Own	26.75%	Shs Outstand	35.99M	Perf Week	6.71%
Market Cap	160.27M	Forward P/E	-	EPS next Y	-1.04	Insider Trans	-0.52%	Shs Float	26.38M	Perf Month	4.22%
Enterprise Value	74.98M	PEG	-	EPS next Q	-0.23	Inst Own	60.13%	Short Float	4.58%	Perf Quarter	-18.20%
Income	-34.55M	P/S	-	EPS this Y	17.24%	Inst Trans	14.48%	Short Ratio	3.74	Perf Half Y	286.96%
Sales	0.00M	P/B	1.96	EPS next Y	-8.33%	ROA	-40.93%	Short Interest	1.21M	Perf YTD	290.35%
Book/sh	2.27	P/C	1.88	EPS next 5Y	-	ROE	-44.56%	52W High	6.91 -35.60%	Perf Year	290.35%
Cash/sh	2.37	P/FCF	-	EPS past 3/5Y	19.17% -8.39%	ROIC	-42.26%	52W Low	1.00 345.00%	Perf 3Y	-40.90%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	10.39% 9.68%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	27.21%	Oper. Margin	-	ATR (14)	0.40	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	15.73	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	54.47	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	15.73	EPS Q/Q	16.91%	SMA20	1.39%	Beta	-0.96	Target Price	9.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	7.71%	Rel Volume	0.67	Prev Close	4.20
Employees	21	LT Debt/Eq	0.00	Earnings	May 11 AMC	SMA200	103.13%	Avg Volume	322.50K	Price	4.45
IPO	Mar 25, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	230,503	Change	5.95%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)